Supplements

Early adenotonsillectomy increases clinically-meaningful benefit compared to watchful waiting in children with mild sleep-disordered breathing

In a secondary analysis of the PATS randomized trial, 65% of children who received early adenotonsillectomy (eAT) experienced clinically-meaningful improvement on at least 2 of 4 domains (behavior, quality of life, subjective sleepiness, blood pressure) versus 39% in the watchful waiting group (p<0.01). A high Mallampati score (III or IV) was the only predictor of benefit (OR 4.16, 95% CI [1.22, 15.6], p=0.027).

Last updated: Jul 13, 2026•1 RCTs•📖 Read as article →

Evidence Score

Evidence Score44/100
Human RCT★★☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. Adenotonsillectomy for Children with Mild Sleep-Disordered Breathing: Who Benefits?

observational

Chervin RD, Gueye-Ndiaye S, Cen M, Mitchell RB, Liu C, Ibrahim S, George A, Hjelm M, Kirkham EM, Baldassari CM, Wang R, Redline S, Rosen CL · Sleep (2026)

Participants: N/A
Duration: 12 months
Intervention: Early adenotonsillectomy (eAT) versus watchful waiting with supportive care (WWSC)
Outcome: Clinically-meaningful benefit defined as clinically-significant change in at least 2 of 4 domains: behavior, quality of life, subjective sleepiness, and blood pressure
Effect Size: OR 4.16 for high Mallampati score predicting benefit
Population: Children aged 3.0-12.9 years with mild sleep-disordered breathing (snoring but little or no obstructive sleep apnea); mean age 6.6 years, 55% >5 years, 51% male

Result:

PubMed: 42421252DOI: 10.1093/sleep/zsag169

Mechanism Graph

Adenotonsillectomy removes enlarged tonsils and adenoids
↓
Reduces upper airway obstruction during sleep
↓
Improves ventilation and sleep quality
↓
Result: Clinically-meaningful improvements in behavior, quality of life, sleepiness, and blood pressure

Limitations

  • ⚠Secondary analysis of a randomized trial, not a primary outcome
  • ⚠Only one predictor (Mallampati score) identified, limiting clinical utility for patient selection

Frequently Asked Questions

What is the definition of clinically-meaningful benefit in this study?▼

Clinically-meaningful benefit was defined as a composite outcome of clinically-significant change in at least 2 of 4 domains: behavior, quality of life, subjective sleepiness, and blood pressure.

What is a Mallampati score and why is it relevant?▼

The Mallampati score is a visual assessment of oropharyngeal size; a high score (III or IV) indicates a relatively small airway. In this study, it was the only baseline feature that predicted which children would benefit from adenotonsillectomy.

How many children benefited from early adenotonsillectomy compared to watchful waiting?▼

65% of children in the early adenotonsillectomy group experienced clinically-meaningful improvement, compared to 39% in the watchful waiting group (p<0.01).

Does this study support routine adenotonsillectomy for all children with mild sleep-disordered breathing?▼

No, the study found that most clinical features did not predict benefit, except for a high Mallampati score. This suggests that patient selection remains challenging and that not all children will benefit equally.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Chervin RD, Gueye-Ndiaye S, Cen M, Mitchell RB, Liu C, Ibrahim S, George A, Hjelm M, Kirkham EM, Baldassari CM, Wang R, Redline S, Rosen CL. "Adenotonsillectomy for Children with Mild Sleep-Disordered Breathing: Who Benefits?." Sleep, 2026. PMID: 42421252 DOI: 10.1093/sleep/zsag169
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.